Molecular monitoring of treatment efficacy in human visceral leishmaniasis

© The Author(s) 2024. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene..

BACKGROUND: Focused efforts of the visceral leishmaniasis elimination program have led to a drastic decline in cases, and the present challenge is disease monitoring, which this study aimed to assess.

METHODS: A Leishmania kinetoplastid-targeted qPCR quantified parasite load at disease presentation, and following treatment completion (n=49); an additional 80 cases were monitored after completion of treatment.

RESULTS: The parasite load at disease presentation was 13 461.00 (2560.00-37764.00)/µg gDNA, which upon completion of treatment reduced in 47 of 49 cases to 1(1-1)/µg gDNA, p<0.0001. In 80 cases that presented >2 months post-treatment, their parasite burden similarly decreased to 1(1-1)/µg gDNA except in 6 of 80 cases, which were qPCR positive.

CONCLUSION: In 129 cases of visceral leishmaniasis, qPCR by quantification of parasite burden proved effective for monitoring treatment.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - year:2024

Enthalten in:

Transactions of the Royal Society of Tropical Medicine and Hygiene - (2024) vom: 15. Jan.

Sprache:

Englisch

Beteiligte Personen:

Roy, Sutopa [VerfasserIn]
Moulik, Srija [VerfasserIn]
Chaudhuri, Surya Jyati [VerfasserIn]
Ghosh, Manab K [VerfasserIn]
Goswami, R P [VerfasserIn]
Saha, Bibhuti [VerfasserIn]
Chatterjee, Mitali [VerfasserIn]

Links:

Volltext

Themen:

Amphotericin B
Deoxycholate drug combination
Journal Article
Liposomal amphotericin
Parasite load
Quantitative real-time polymerase chain reaction
Visceral leishmaniasis

Anmerkungen:

Date Revised 15.01.2024

published: Print-Electronic

Citation Status Publisher

doi:

10.1093/trstmh/trad103

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM367144727